Sponsor Pipeline

Palvella Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05643872 A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel… Pachyonychia Congenita Recruiting
NCT06239480 SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of… Microcystic Lymphatic Malformation Active, Not Recruiting
Phase 2
NCT07552077 A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022… Angiokeratomas Recruiting
NCT06653842 A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022… Cutaneous Venous Malformations Active, Not Recruiting
Get alerts when Palvella Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free